STEVEN SHIELD: Open Payments
NPI 1619954237 · GROVELAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| ABBVIE INC. | 1 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Amgen Inc. | 1 | $14 |
Products named: HETLIOZ, MAVYRET, VOWST, Ozempic, Kerendia, EVENITY.
Industry payments across CA — which companies pay providers there.
